EN
EN
Shenzhen Zhongjia Biomedical Technology Co., Ltd. (hereinafter referred to as "Zhongjia Bio") is a national high-tech enterprise dedicated to biomedical technology R&D and innovation. It has made deep inroads into the cell and gene therapy (CGT) field, ranking among the top CGT companies in China. Relying on full-industry-chain technological innovation and a high-standard quality system, the company has provided core technical support to nearly 1,000 Grade-A tertiary hospitals, research institutions, and CGT R&D enterprises nationwide. Zhongjia Bio actively pursues a globalization strategy, building products and services that meet international quality standards. Thanks to its outstanding technical R&D barriers and reliable product quality, its services now cover the United States, Canada, Southeast Asia, and other countries and regions, making it one of China's representative enterprises exporting high-standard CGT to the world. The company is committed to breaking down key technical barriers in biomedicine, demonstrating strong Chinese scientific and technological strength on the international track of innovative CGT drugs and technical services.
Zhongjia Bio possesses strong industrialization strength and R&D foundations, with a 12,000-square-meter pharmaceutical building meeting GMP standards (Yinxing Base) and a 1,600-square-meter cutting-edge R&D center (Gaoke Base). Driven by independent innovation, the company has successfully mastered 19 core industry technologies and built 9 innovative R&D platforms. It has passed dual international certifications of ISO 9001:2015 (Quality Management System) and ISO 13485:2016 (Medical Device Quality Management System), and obtained 4 U.S. FDA DMF filings, ensuring compliance, safety, and international quality throughout the entire product lifecycle. As a leader in industry standardization, Zhongjia Bio led the drafting of the industry standard "Preparation Specification for Human Blood-Derived Natural Killer Cell Products." With outstanding scientific research and transformation capabilities, the company has been recognized as a National High-tech Enterprise, Synthetic Biology Enterprise, Specialized, Refined, Unique and Innovative Enterprise, and approved to establish a Guangdong Provincial Doctoral Innovation Station and a Shenzhen Postdoctoral Innovation Practice Base, continuously building a highland of high-end talent and scientific innovation. Guided by the national innovation-driven development strategy, Zhongjia Bio has taken the lead in clinical trials of multiple cutting-edge cell-based drugs targeting neurodegenerative diseases, tumors, diabetes, and other conditions, continuously promoting the standardization and large-scale development of China's CGT industry. Ranking at the forefront of China's CGT industry and radiating to North America and Southeast Asia, Zhongjia Bio reshapes the miracle of life with core technology, building a world-leading full-industry-chain service platform for cell and gene therapy.
Zhongjia Bio always adheres to the core development philosophy of "Technology Leadership, Safety First," embedding high-standard quality management throughout the closed loop of the full industry chain: from cutting-edge R&D, to large-scale production, to clinical application. Upholding the corporate mission of "Forge Core Technology; Quality Matters More Than Life," the company is committed to providing customers with safe, reliable, and efficient CGT products and services through a strict compliance system and superior technical quality.
12000
Pharmaceutical Building Area (㎡)
300
Employees
60
IP Rights (Items)
20
Export Countries









































Invention Patent Certificate

Invention Patent Certificate

Invention Patent Certificate

Invention Patent Certificate

Invention Patent Certificate

Invention Patent Certificate

Invention Patent Certificate

Invention Patent Certificate

Invention Patent Certificate

Invention Patent Certificate

Invention Patent Certificate

Invention Patent Certificate

Invention Patent Certificate

Computer Software Copyright Registration Certificate

Utility Model Patent Certificate